Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06116461
Title Nivolumab Dose Optimization in Patients With a Complete, Partial or Stable Response (NIVOPTIMIZE)
Acronym NIVOPTIMIZE
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Erasmus Medical Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries NLD


No variant requirements are available.